SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
clinical 1,334 words KG: Als
Contents

Low-Dose Naltrexone ALS Trial

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (127)

Temporal Decoupling via Circadian Clock Reset
Score: 0.54Lysosomal Membrane Repair Enhancement
Score: 0.54Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption
Score: 0.47AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.82Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.79Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.79Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.78Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.77Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.75Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74Epigenetic Memory Erasure via TET2 Activation
Score: 0.74PARP1 Inhibition Therapy
Score: 0.74SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.74Senescence-Induced Lipid Peroxidation Spreading
Score: 0.73TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.73Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.72Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.72HDAC3-Selective Inhibition for Clock Reset
Score: 0.71
← Prevpg 4/7Next →

Related Analyses (17)

RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completedCRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archivedMicroglial subtypes in neurodegeneration — friend vs foe
neuroscience · archived

Related Experiments (30)

Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40Environmental Exposure Causal Attribution in ALS — Experimen
validation · proposed · Score: 0.40FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio
validation · proposed · Score: 0.40

See Also (2)

A2M Gene
gene · KG edge: interacts_withABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates

Knowledge Graph (12 edges)

STATHMIN-2 inhibits Als
HERV-K contributes_to Als
LGALS9 regulates Als
NADH therapeutic_target Als
HSP90 activates Als
ITGA2B regulates Als
ERK1/2 activates Als
IL-18 activates Als
IL-1 activates Als
AKR1B10 associated_with Als

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.
SciDEX — scidex.ai — Dashboard | Atlas